ALPS Medical Breakthroughs ETF Rating $67.31 -0.58 (-0.85%) As of 09/3/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.73Holdings in SBIO have an aggregate rating of Moderate Buy based on 348 analyst ratings issued in the past year covering 25 companies (57.9% of the portfolio).SBIO Aggregate Price Target$67.31High Prediction$67.31Average Prediction$67.31Low Prediction$67.31Holdings in SBIO have an aggregate price target of $67.31 and a range of $67.31 to $67.31 covering 25 companies (57.9% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 SBIO Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.55%CRNXCrinetics Pharmaceuticals$84.951.4605 of 5 stars2.24$81.00 -4.6%17Analyst Forecast4.24%APGEApogee Therapeutics$135.10+0.0%1.5395 of 5 stars2.16$126.77 -6.2%19News CoverageHigh Trading Volume3.41%ORKAOruka Therapeutics$90.99-0.7%2.8537 of 5 stars2.82$133.00 46.2%11Positive NewsAnalyst ForecastInsider Trade3.37%CGONCG Oncology$74.33-0.3%3.2401 of 5 stars2.77$83.18 11.9%13Positive News3.23%DNTHDianthus Therapeutics$107.85+1.5%2.1778 of 5 stars2.93$124.27 15.2%14Positive NewsInsider Trade3.07%XENEXenon Pharmaceuticals$60.40+0.4%2.5545 of 5 stars3.00$77.13 27.7%17Positive NewsInsider Trade2.94%TVTXTravere Therapeutics$66.54-1.0%1.6624 of 5 stars2.69$61.67 -7.3%13Positive News2.46%ACADACADIA Pharmaceuticals$27.86-3.7%4.8293 of 5 stars2.78$34.36 23.3%18Positive News2.42%EWTXEdgewise Therapeutics$41.95-0.1%3.4088 of 5 stars2.82$50.33 20.0%11News CoveragePositive News2.39%MANEVeradermics$97.70-0.8%2.7754 of 5 stars2.67$153.00 56.6%92.37%DFTXDefinium Therapeutics$38.00-2.3%3.8557 of 5 stars3.00$63.00 65.8%202.20%RLAYRelay Therapeutics$19.01+2.7%2.9187 of 5 stars2.93$25.92 36.3%14Positive News2.17%DYNDyne Therapeutics$24.95-0.8%3.6477 of 5 stars2.87$34.42 37.9%15Positive News1.98%GPCRStructure Therapeutics$47.34-1.0%2.3042 of 5 stars2.89$110.91 134.3%18Positive News1.97%DNLIDenali Therapeutics$22.80-0.2%3.2936 of 5 stars2.76$35.85 57.2%17Positive News1.68%CLDXCelldex Therapeutics$39.37-0.3%2.7971 of 5 stars2.85$56.08 42.5%13Positive News1.66%MBXMBX Biosciences$61.42+0.9%2.7595 of 5 stars2.77$77.00 25.4%13Positive News1.63%IDYAIDEAYA Biosciences$39.97-0.5%2.807 of 5 stars2.82$50.87 27.3%17Positive NewsAnalyst Forecast1.61%NAMSNewAmsterdam Pharma$25.85+1.0%2.1772 of 5 stars2.92$49.73 92.4%131.57%IMNMImmunome$27.16-0.6%3.0439 of 5 stars2.85$34.64 27.5%13Positive News1.53%IRONDisc Medicine$79.37-0.8%2.5264 of 5 stars2.75$107.70 35.7%12Trending NewsAnalyst ForecastInsider Trade1.51%TARSTarsus Pharmaceuticals$83.21+0.5%2.3923 of 5 stars2.78$90.50 8.8%9Positive NewsInsider Trade1.44%ZLABZai Lab$27.00+2.0%2.5634 of 5 stars2.71$37.25 38.0%71.26%NKTRNektar Therapeutics$76.37+5.0%2.5014 of 5 stars2.77$141.50 85.3%131.26%BCRXBioCryst Pharmaceuticals$10.09-0.8%3.0526 of 5 stars2.67$20.60 104.2%12Positive News This page (NYSEARCA:SBIO) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
